Novartis–Biognosys: proteomic services, 201104– supply service Targeted Proteomics techn for undisclosed discovery area of Novartis Vaccines Siena

	Period	2011-04-18
	Partner, 1st	Novartis Vaccines and Diagnostics Srl
	Group	Novartis (Group)
	Partner, 2nd	Biognosys AG
	Product	proteomic services
	Product 2	drug discovery

Redalpine Venture Partners AG. (4/18/11). "Press Release: Biognosys Enters a Collaboration with Novartis".

Biognosys is entering into a collaboration with Novartis Vaccines and Diagnostics, for which it will apply its proprietary Targeted Proteomics technology platform to an undisclosed discovery area. After having successfully worked for two leading global pharmaceutical companies players in 2010, the newly closed deal with Novartis Vaccines and Diagnostics in Siena is an additional highlight of a successful start into 2011.

Since the company began operations in 2010, Biognosys has provided its targeted proteomics technology to identify and quantify proteins for companies in life sciences and healthcare such as Novartis, Pfizer, Integrated Diagnostics, and Philips.

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Novartis–Biognosys: proteomic services, 201104– supply service Targeted Proteomics techn for undisclosed discovery area of Novartis Vaccines Siena

Redalpine Venture Partners AG. (4/18/11). "Press Release: Biognosys Enters a Collaboration with Novartis".

More documents for Novartis (Group)